Cohbar Price to Sales Ratio 2014-2019 | CWBR

Historical PS ratio values for Cohbar (CWBR) over the last 10 years. The current P/S ratio for Cohbar as of October 21, 2019 is .
Cohbar P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-10-22 1.57 inf
2019-06-30 1.72 0 0.00
2019-03-31 3.26 0 0.00
2018-12-31 3.11 0 0.00
2018-09-30 4.31 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.064B $0.000B
Cohbar, Inc. operates is a biotechnology company. It engaged in the research and development of mitochondria-based therapeutics for the treatment of diseases associated with aging. Cohbar, Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.697B 13.86
Gilead Sciences (GILD) United States $82.586B 10.14
CSL (CSLLY) Australia $78.316B 0.00
Celgene (CELG) United States $73.284B 11.34
Vertex Pharmaceuticals (VRTX) United States $47.174B 50.98
Illumina (ILMN) United States $46.133B 54.20
Biogen (BIIB) United States $41.226B 7.32
Regeneron Pharmaceuticals (REGN) United States $32.729B 14.85
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.586B 11.91
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.902B 49.74
Seattle Genetics (SGEN) United States $16.316B 0.00
Genmab (GNMSF) Denmark $13.038B 73.13
BioMarin Pharmaceutical (BMRN) United States $12.279B 0.00
Exact Sciences (EXAS) United States $12.015B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.648B 0.00
Galapagos (GLPG) Belgium $8.635B 0.00
Bio-Techne Corp (TECH) United States $7.707B 53.24
Sarepta Therapeutics (SRPT) United States $6.439B 0.00
QIAGEN (QGEN) Netherlands $6.339B 20.82
BeiGene (BGNE) Cayman Islands $6.315B 0.00
Guardant Health (GH) United States $6.292B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.248B 0.00
Amarin (AMRN) Ireland $5.783B 0.00
Reata Pharmaceuticals (RETA) United States $5.478B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.165B 13.13
Moderna (MRNA) United States $5.118B 0.00
Exelixis (EXEL) United States $5.095B 13.24
Bluebird Bio (BLUE) United States $5.056B 0.00
Medicines (MDCO) United States $4.569B 0.00
China Biologic Products (CBPO) China $4.500B 28.09
ARGENX SE-ADR (ARGX) Netherlands $4.377B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.043B 78.46
Spark Therapeutics (ONCE) United States $3.880B 0.00
Blueprint Medicines (BPMC) United States $3.864B 0.00
MorphoSys AG (MOR) Germany $3.438B 0.00
Immunomedics (IMMU) United States $3.037B 0.00
Mirati Therapeutics (MRTX) United States $2.985B 0.00
Alkermes (ALKS) Ireland $2.893B 0.00
Emergent Biosolutions (EBS) United States $2.687B 40.36
Genmab (GMAB) Denmark $2.665B 0.00
MyoKardia (MYOK) United States $2.616B 0.00
Genomic Health (GHDX) United States $2.574B 48.28
Arena Pharmaceuticals (ARNA) United States $2.475B 5.32
Ultragenyx Pharmaceutical (RARE) United States $2.422B 0.00
Myriad Genetics (MYGN) United States $2.327B 24.25
Halozyme Therapeutics (HALO) United States $2.244B 0.00
Acceleron Pharma (XLRN) United States $2.241B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.218B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.189B 0.00
RA PHARMCTL INC (RARX) United States $2.174B 0.00
NeoGenomics (NEO) United States $2.111B 112.94
Amicus Therapeutics (FOLD) United States $2.108B 0.00
Ligand Pharmaceuticals (LGND) United States $2.064B 26.10
Cambrex (CBM) United States $2.005B 25.35
Zai Lab (ZLAB) China $1.908B 0.00
Akcea Therapeutics (AKCA) United States $1.762B 0.00
UniQure (QURE) Netherlands $1.643B 0.00
Insmed (INSM) United States $1.628B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Denali Therapeutics (DNLI) United States $1.454B 0.00
REGENXBIO (RGNX) United States $1.447B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.418B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Coherus BioSciences (CHRS) United States $1.338B 0.00
Zymeworks (ZYME) Canada $1.197B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.178B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.124B 0.00
Innoviva (INVA) United States $1.107B 3.20
Alector (ALEC) United States $1.033B 0.00
Editas Medicine (EDIT) United States $1.013B 0.00
AnaptysBio (ANAB) United States $0.993B 0.00
Sangamo Therapeutics (SGMO) United States $0.980B 0.00
Epizyme (EPZM) United States $0.978B 0.00
Fate Therapeutics (FATE) United States $0.950B 0.00
ANI Pharmaceuticals (ANIP) United States $0.918B 15.33
Achillion Pharmaceuticals (ACHN) United States $0.856B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Zealand Pharma (ZEAL) Denmark $0.845B 9.48
Codexis (CDXS) United States $0.793B 0.00
Twist Bioscience (TWST) United States $0.786B 0.00
Anika Therapeutics (ANIK) United States $0.785B 27.79
Cara Therapeutics (CARA) United States $0.778B 0.00
Principia Biopharma (PRNB) United States $0.752B 389.13
Athenex (ATNX) United States $0.742B 0.00
WAVE Life Sciences (WVE) Singapore $0.741B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.23
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Vericel (VCEL) United States $0.699B 0.00
Revance Therapeutics (RVNC) United States $0.691B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.673B 0.00
Cytokineticsorporated (CYTK) United States $0.667B 0.00
Heska (HSKA) United States $0.578B 74.86
Mesoblast (MESO) Australia $0.572B 0.00
MiMedx (MDXG) United States $0.564B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
GENFIT S.A (GNFT) France $0.538B 0.00
Arvinas (ARVN) United States $0.537B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.511B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Retrophin (RTRX) United States $0.489B 0.00
BioDelivery Sciences (BDSI) United States $0.472B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
UROGEN PHARMA (URGN) United States $0.463B 0.00
Intra-Cellular Therapies (ITCI) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Adverum Biotechnologies (ADVM) United States $0.456B 0.00
DBV Technologies S.A (DBVT) France $0.450B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.450B 0.00
Cellectis S.A (CLLS) France $0.442B 0.00
Stemline Therapeutics (STML) United States $0.408B 0.00
Kadmon Holdings (KDMN) United States $0.401B 0.00
Bellus Health (BLU) Canada $0.396B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.389B 0.00
Arcus Biosciences (RCUS) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.378B 0.00
Agenus (AGEN) United States $0.352B 0.00
AC Immune SA (ACIU) Switzerland $0.351B 26.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 0.00
Precision BioSciences (DTIL) United States $0.334B 0.00
Prothena (PRTA) Ireland $0.333B 0.00
Kindred Biosciences (KIN) United States $0.320B 0.00
CytomX Therapeutics (CTMX) United States $0.320B 0.00
Protagonist Therapeutics (PTGX) United States $0.316B 0.00
Avid Bioservices (CDMO) United States $0.301B 0.00
Gritstone Oncology (GRTS) United States $0.296B 0.00
Pfenex (PFNX) United States $0.293B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
Starpharma Holdings (SPHRY) Australia $0.288B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.284B 0.00
ADMA Biologics Inc (ADMA) United States $0.283B 0.00
Geron (GERN) United States $0.279B 0.00
PDL BioPharma (PDLI) United States $0.279B 7.18
Dynavax Technologies (DVAX) United States $0.278B 0.00
Syros Pharmaceuticals (SYRS) United States $0.273B 0.00
Scholar Rock Holding (SRRK) United States $0.273B 0.00
Puma Biotechnology (PBYI) United States $0.270B 0.00
Cel-Sci (CVM) United States $0.266B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.247B 368.33
MannKind (MNKD) United States $0.247B 0.00
OSMOTICA PHARM (OSMT) United States $0.244B 0.00
Seres Therapeutics (MCRB) United States $0.242B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.231B 0.00
Inovio Pharmaceuticals (INO) United States $0.230B 0.00
Albireo Pharma (ALBO) United States $0.229B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
ChromaDex (CDXC) United States $0.217B 0.00
Athersys (ATHX) United States $0.209B 0.00
Kamada (KMDA) Israel $0.209B 7.98
Exicure (XCUR) United States $0.207B 0.00
Sorrento Therapeutics (SRNE) United States $0.207B 0.00
Compugen (CGEN) Israel $0.206B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.197B 0.00
Palatin Technologies (PTN) United States $0.191B 5.61
Clovis Oncology (CLVS) United States $0.188B 0.00
Affimed (AFMD) Germany $0.184B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.184B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Prometic Life Sciences (PFSCF) Canada $0.174B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Senesco Technologies (ELOX) United States $0.157B 0.00
XOMA (XOMA) United States $0.157B 0.00
Arsanis (XFOR) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
BioTime (LCTX) United States $0.145B 9.70
Alcobra (ARCT) United States $0.141B 0.00
Cerecor (CERC) United States $0.141B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.125B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
NantKwest (NK) United States $0.109B 0.00
Novavax (NVAX) United States $0.106B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 4.31
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.104B 0.00
Aptinyx (APTX) United States $0.100B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
VBI Vaccines (VBIV) United States $0.096B 0.00
Antibe Therapeutics (ATBPF) Canada $0.094B 0.00
OvaScience (MLND) United States $0.094B 0.00
Celyad SA (CYAD) Belgium $0.092B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Liquidia Technologies (LQDA) United States $0.085B 0.00
Verastem (VSTM) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Mersana Therapeutics (MRSN) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Aduro Biotech (ADRO) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.076B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Orgenesis (ORGS) United States $0.058B 21.18
NewLink Genetics (NLNK) United States $0.056B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.054B 0.00
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.050B 0.00
Arbutus Biopharma (ABUS) Canada $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Unum Therapeutics (UMRX) United States $0.043B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
Celsion (CLSN) United States $0.038B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Proteostasis Therapeutics (PTI) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
Aptevo Therapeutics (APVO) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00